Top in hem/onc: Sugar-sweetened beverages and cancer risk; disparities in breast cancer
Click Here to Manage Email Alerts
Individuals who drank two or more sugar-sweetened beverages daily had a 5% increased risk for mortality from kidney or colorectal cancers compared with those who did not drink any sugar-sweetened beverages, data show.
Researchers also found an association between artificially sweetened beverages and pancreatic cancer risk, independent of BMI. Healio spoke with study coauthor Marjorie L. McCullough, ScD, RD, about the findings and their potential implications. It was the top story in hematology/oncology last week.
The second top story was about a decline in breast cancer mortality rates in the United States and a persistent trend in racial disparities between Black and white women with breast cancer.
Read these and more top stories in hematology/oncology below:
Sugar-sweetened beverages linked to cancer mortality risk
Consumption of sugar-sweetened beverages appeared to be associated with an increased risk for death from an obesity-related cancer, according to study results published in Cancer Epidemiology, Biomarkers & Prevention. Watch video.
Breast cancer death rate declines, but racial disparities have ‘remained unabated’
Breast cancer death rates in the United States declined sharply over the past 30 years but racial disparities persist, according to a report from American Cancer Society. Read more.
Avoid capital gains taxes like a billionaire using ‘buy, borrow, die’ strategy
Often, after speaking about taxes at a medical conference, we are approached by a physician attendee who has read that billionaires, like Warren Buffet and Elon Musk, pay less taxes than they do and they wonder how that can be. Read more.
Medicaid expansion linked to decreased cancer incidence, mortality
Medicaid expansion appeared to be associated with reductions in metastatic cancer incidence and overall cancer mortality, according to study results scheduled for presentation at ASCO Quality Care Symposium. Read more.
Psychedelic therapy could reduce anxiety, distress among patients with cancer
Anxiety and depression that may follow a cancer diagnosis, especially as a patient approaches the end of life, can be incapacitating and difficult to assuage. Read more.